Literature DB >> 3664395

Lower extremity amputations: a 5-year review and comparative study.

R R Lexier1, I J Harrington, J M Woods.   

Abstract

In order to review major lower extremity amputations at the Toronto East General and Orthopaedic Hospital Inc. between 1979 and 1984, 60 patients with 42 below-knee, 17 mid-thigh and 20 Callander through-knee amputations were studied retrospectively. The three amputation groups demonstrated comparable rates of stump healing. A previous history of vascular surgery on the extremity increased the risk for both delayed healing and failure to heal. The Callander through-knee amputees were rehabilitated earlier and more easily than were the mid-thigh amputees, and once rehabilitated they were more likely to continue using their prostheses. The authors recommend that, when possible, the chosen site of amputation for the majority of patients should be below the knee, but when this is not practical a through-knee amputation should be done in preference to a mid-thigh amputation.

Entities:  

Mesh:

Year:  1987        PMID: 3664395

Source DB:  PubMed          Journal:  Can J Surg        ISSN: 0008-428X            Impact factor:   2.089


  4 in total

1.  The status of lower-limb amputation in Bangladesh: a 6-year review.

Authors:  M Aftabuddin; N Islam; M A Jafar; I Haque
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

2.  Amputation for occlusive arterial disease. A prospective multicentre study of 177 amputees.

Authors:  M Eneroth; B M Persson
Journal:  Int Orthop       Date:  1992       Impact factor: 3.075

3.  Phantom pain: natural history and association with rehabilitation.

Authors:  A D Houghton; G Nicholls; A L Houghton; E Saadah; L McColl
Journal:  Ann R Coll Surg Engl       Date:  1994-01       Impact factor: 1.891

4.  Cost of managing complications resulting from type 2 diabetes mellitus in Canada.

Authors:  Judith A O'Brien; Amanda R Patrick; J Jaime Caro
Journal:  BMC Health Serv Res       Date:  2003-03-21       Impact factor: 2.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.